IP Library › Granted Patent US 7,294,700
Granted Patent B2
US 7,294,700 · App. 09/978,665 · Granted Nov 13, 2007

Anti-PRO846 antibodies

Assignee: Genentech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,294,700
App. No.
09/978,665
Granted
Nov 13, 2007
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (4)

1. An isolated antibody, or fragment thereof, that specifically binds to the polypeptide of SEQ ID NO:216.

2. The antibody of claim 1 which is a monoclonal antibody.

3. The antibody of claim 1 which is a humanized antibody.

4. The antibody of claim 1 which is labeled.

Continuity (6)
Continuation 0991858500 · Jul 30, 2001
Continuation PCTUS000434100 · Feb 18, 2000
Continuation In Part 0938013800
Provisional Application 6012395700 · Mar 12, 1999
Provisional Application 6008460000 · May 7, 1998
Related Publication 20030199437A1 · Oct 23, 2003